Ampio Pharmaceuticals Inc (AMPE)
0.4961
+0.25
(+104.99%)
USD |
OTCM |
Apr 19, 15:48
Ampio Pharmaceuticals Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | -0.097M |
| September 30, 2021 | -0.112M |
| June 30, 2021 | -0.144M |
| March 31, 2021 | -0.144M |
| December 31, 2020 | -0.063M |
| September 30, 2020 | -0.056M |
| June 30, 2020 | -0.008M |
| March 31, 2020 | -0.017M |
| December 31, 2019 | -0.022M |
| September 30, 2019 | -0.0923M |
| June 30, 2019 | -0.1359M |
| March 31, 2019 | -0.3805M |
| December 31, 2018 | -0.564M |
| September 30, 2018 | -0.5247M |
| June 30, 2018 | -0.497M |
| March 31, 2018 | -0.2434M |
| December 31, 2017 | -0.0723M |
| September 30, 2017 | -0.0402M |
| June 30, 2017 | -0.0243M |
| March 31, 2017 | -0.0243M |
| December 31, 2016 | -0.0068M |
| September 30, 2016 | -16.96M |
| June 30, 2016 | -16.99M |
| March 31, 2016 | -18.03M |
| December 31, 2015 | -18.08M |
| Date | Value |
|---|---|
| September 30, 2015 | -7.381M |
| June 30, 2015 | -9.367M |
| March 31, 2015 | -11.18M |
| December 31, 2014 | -14.18M |
| September 30, 2014 | -8.964M |
| June 30, 2014 | -6.950M |
| March 31, 2014 | -4.102M |
| December 31, 2013 | -1.665M |
| September 30, 2013 | -0.5988M |
| June 30, 2013 | -0.5988M |
| March 31, 2013 | -0.5899M |
| December 31, 2012 | 0.015M |
| September 30, 2012 | 0.002M |
| June 30, 2012 | -0.0444M |
| March 31, 2012 | -0.1197M |
| December 31, 2011 | -0.1197M |
| September 30, 2011 | -0.1193M |
| June 30, 2011 | -0.0729M |
| March 31, 2011 | 0.00 |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | 0.00 |
| September 30, 2009 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.144M
Minimum
Mar 2021
-0.008M
Maximum
Jun 2020
-0.081M
Average
-0.0923M
Median
Sep 2019
Cash from Investing (TTM) Benchmarks
| NeuBase Therapeutics Inc | -0.0548M |
| Tivic Health Systems Inc | -0.118M |
| Oragenics Inc | -0.9363M |
| Actinium Pharmaceuticals Inc | -0.153M |
| MAIA Biotechnology Inc | -- |